Concepedia

Melissa Kirkland

MK

Statistics

Publications

9

Citations

220

H-Index

9

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

Melissa Kirkland is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

1996–2024

9

Publications

9

Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists

Jason M. Cox, Hong D. Chu, Mariappan V. Chelliah et al. · ACS Medicinal Chemistry Letters · 2016 · 34 citations · Full text

, , +17

Design and Synthesis of Novel, Selective GPR40 AgoPAMs

Christopher W. Plummer, Matthew J. Clements, Helen Chen et al. · ACS Medicinal Chemistry Letters · 2017 · 34 citations · Full text

, , +15

Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with <i>in Vivo</i> Activity in Rodents

Gregory L. Adams, Francisco Velázquez, Charles Jayne et al. · ACS Medicinal Chemistry Letters · 2016 · 32 citations · Full text

, , +11

<i>N</i>-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  K<sub>ATP</sub> Potassium Channel Openers. Modifications on the Western Region

Cyrus J. Ohnmacht, Keith C. Russell, James R. Empfield et al. · Journal of Medicinal Chemistry · 1996 · 26 citations

, , +17

Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects

Matthew Lombardo, Kate Bender, Clare London et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 25 citations · Full text

, , +16

1–5 of 9